Maynard Um
-
-
-
-
-
-
-
CervoMed presents neflamapimod DLB trial data at AAIC 2026
-
-
-
-
-
-
-
CervoMed's neflamapimod selected for UK ALS trial platform
-
-
-
-
-
-
-
CervoMed reports positive Phase 2b trial results for dementia drug
-
-
-
-
-
-
-
Jones Trading Upgrades CervoMed (CRVO) to Buy
-
-
-
-
-
-
-
Chardan Capital Markets Downgrades CervoMed (CRVO) to Neutral
-
-
-
-
-
-
-
CervoMed (CRVO) Announces Key Senior Leadership Appointments
-
-
-
-
-
-
-
BofA Securities Reiterates Buy Rating on Grupo Aeroportuario Del Sureste (ASURB:MM) (ASR), Top Pick
-
470,457 total articles have been posted to this entity.
Click Here to Sign-Up for StreetInsider.com Premium to View All


